CIK 0001600620 · Large accelerated filer
Aurinia Pharmaceuticals Inc.
Sign in to watch- Ticker
- AUPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981231763
- Phone
- 250-744-2487
- Business address
- #140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
- 8-K Event Acquisition or sale completed
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- 8-K Event Other events
- 8-K Event Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- 10-Q Report Quarterly Report
Page 1 of 5 · 84 filings